This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction. Newer Drugs for Older Patients

Dilip V. Jeste, MD

Published: June 1, 1999

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The entry of chlorpromazine into the psychopharmacologic armamentarium againstschizophrenia and other psychotic disorders in 1952 started a new era in psychiatric management of severely mentally ill people. Chlorpromazine and other neuroleptic or antipsychotic drugs that followed it controlled the positive symptoms of psychosis such as delusions and hallucination far better than any of the previous treatments ever did. Equally importantly, they markedly reduced the risk of relapse in patients with chronic schizophrenia, schizoaffective disorder, and related conditions.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Populations

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500...